financetom
Business
financetom
/
Business
/
AI startup Anthropic to raise $2 billion at $60 billion valuation, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AI startup Anthropic to raise $2 billion at $60 billion valuation, sources say
Jan 7, 2025 4:47 PM

(Reuters) -AI startup Anthropic is near a deal to raise an additional $2 billion at a price that values the company at $60 billion, sources said, months after its $4 billion funding from Amazon.

Venture capital firm Lightspeed Venture Partners is leading the funding round, according to the sources, who requested anonymity to discuss private matters.

The new funding, $6 billion in total, will mark a jump in valuation for Anthropic, a major competitor of OpenAI in the foundation model space. Anthropic was valued at around $18 billion in a fundraise led by Menlo Ventures last year.

Anthropic declined to comment. The Wall Street Journal first reported the funding on Tuesday.

Amazon late last year doubled its investment in the startup to $8 billion, as the e-commerce giant went up against Big Tech rivals in a race to capitalize on generative AI technology. The latest $4 billion issued to Amazon in convertible notes will be converted into equity through this round.

Anthropic, whose annualized revenue hit about $875 million, sells access to its models directly and through third-party cloud services including Amazon Web Services. The large language models development requires expensive computing, as well as top talents.

Co-founded by former OpenAI executives and siblings Dario and Daniela Amodei, San Francisco-based Anthropic also received $2 billion investment from Alphabet in 2023.

Microsoft-backed OpenAI triggered an AI arms race after it launched ChatGPT in November 2022. The growing popularity of the company and new product launches helped it close a $6.6 billion funding round in October, potentially taking its valuation to $157 billion.

With outsized funding rounds by companies such as Anthropic and xAI, AI startups have accounted for nearly half of the venture capital dollar raised in the U.S. last year, according to PitchBook data.

(Reporting by Anna Tong in San Francisco, Krystal Hu in New York, Akash Sriram in Bengaluru and Juby Babu in Mexico City; Editing by Devika Syamnath, Alan Barona and Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck Receives 2 Positive Opinions for Keytruda in Europe
Merck Receives 2 Positive Opinions for Keytruda in Europe
Sep 21, 2025
07:27 AM EDT, 09/19/2025 (MT Newswires) -- Merck ( MRK ) said Friday the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted two positive opinions for Keytruda. One opinion recommends the approval of a new subcutaneous route of administration and a new pharmaceutical form for Keytruda, while the other recommends approval of a new indication in...
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Sep 21, 2025
07:23 AM EDT, 09/19/2025 (MT Newswires) -- Canada will release retail sales data for July and provide an advance estimate for August at 8:30 a.m. ET on Friday, said Bank of Montreal (BMO). Canadian consumers likely took a step back in July, with an estimated 0.8% month-over-month decline in retail sales, retracing about half of the prior month's gain, noted...
Vodafone, Digi Romania Sign Deals to Acquire Parts of Telekom Romania
Vodafone, Digi Romania Sign Deals to Acquire Parts of Telekom Romania
Sep 21, 2025
07:23 AM EDT, 09/19/2025 (MT Newswires) -- Vodafone Group ( VOD ) said Friday that Vodafone Romania and Digi Romania have signed deals with Hellenic Telecommunications to buy separate parts of the latter's Telekom Romania Mobile Communications unit. Under the terms, Vodafone will acquire the unit and its post-paid client base for 30 million euros ($35.3 million), while Digi Romania...
Ionis Pharmaceuticals, Sobi's Familial Chylomicronemia Treatment Approved by EU
Ionis Pharmaceuticals, Sobi's Familial Chylomicronemia Treatment Approved by EU
Sep 21, 2025
07:27 AM EDT, 09/19/2025 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) and Sobi said Friday that Tryngolza has been approved in the European Union (EU) as an adjunct to diet in adult patients for the treatment of genetically confirmed familial chylomicronemia syndrome. The approval follows the positive opinion by the Committee for Medicinal Products for Human Use and positive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved